A groundbreaking conference at the University of Scranton aims to tackle the complex ethical dilemmas posed by AI, bringing together voices from academia, media, and even the Church.
Anthropic's $400 million acquisition of Coefficient Bio signals a seismic shift in drug discovery, merging AI with biotech to tackle humanity's toughest health challenges.
A groundbreaking conference at the University of Scranton aims to tackle the complex ethical dilemmas posed by AI, bringing together voices from academia, media, and even the Church.
Anthropic's $400 million acquisition of Coefficient Bio signals a seismic shift in drug discovery, merging AI with biotech to tackle humanity's toughest health challenges.
A groundbreaking survey reveals the complex relationship between AI and higher education, highlighting both its transformative potential and ethical concerns.